Indoco Remedies Ltd. announced on Tuesday, the receipt of Establishment Inspection Report (EIR) for its Clinical Research Organisation, AnaCipher, located at Hyderabad for the inspection carried out by the United States Food and Drug Administration (division of New Drug Bioequivalence Evaluation) from 5th August to 9th August, 2019.
The inspection was successfully conducted without any observations and stands closed now.
The CRO - AnaCipher conducts Bioequivalence and Bioavailability (BA/BE) studies at its facility spread over an area of 30,000 sq. ft. with 98 beds. The CRO also has expertise in Bioanalytical work for new chemical entities (Phase I-III studies).
Stock View:
Indoco Remedies Ltd is currently trading at Rs159.70 up by Rs5.15 or 3.33% from its previous closing of Rs154.55 on the BSE.
The scrip opened at Rs157.80 and has touched a high and low of Rs164 and Rs157.55 respectively. So far 47,655 (NSE+BSE) shares were traded on the counter.
The current market cap of the company is Rs1,424.18cr.
For Quick Trial – 8871888787
or mail us here - support@researchicon.com
or visit - http://www.researchicon.com/free-trial
Post a Comment